EP3261658
DOSES AND METHODS OF ADMINISTERING TELAVANCIN
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.2.2016EP published:
3.4.2019EP application number:
16708853.3
EPO information:
European Patent Register
Max expiry date:
17.2.2036
Title:
DOSES AND METHODS OF ADMINISTERING TELAVANCIN
Timeline
Today
18.2.2016EP application
3.4.2019EP Publication
Owner
Name:
Cumberland Pharmaceuticals Inc.Address:
2525 West End Avenue Suite 950, 37203, Nashville, TN, US
Inventor
Name:
BARRIERE, Steven L.Address:
San Francisco, California, US
Name:
LO, ArthurAddress:
San Francisco, California, US
Name:
MAMMEN, MathaiAddress:
Menlo Park, California, US
Name:
WORBOYS, PhilipAddress:
San Mateo, California, US
Priority
Number:
201562119592 PDate:
23.2.2015Country:
US
Classification
Categories:
A61K 38/12, A61P 31/00